EDGAR CONRAD: Open Payments
NPI 1124055074 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 3 payments from 3 companies in 2025. Trend: 2023 $261 · 2024 $586 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
Products named: Auvelity, INGREZZA, REXULTI.
Industry payments across MO — which companies pay providers there.
